Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics Inc.
WKN: A0MSMZ / Symbol: FOLD / Name: Amicus / Aktie / Pharmazeutika / Mid Cap /
9,10 €
-
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $21.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for FOLD provided by MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $18.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in Valvoline Inc diskutieren